Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid beta-Protein Precursor | 13 | 2023 | 1117 | 1.760 |
Why?
|
Ferritins | 5 | 2020 | 601 | 1.460 |
Why?
|
Iron-Regulatory Proteins | 2 | 2020 | 30 | 1.350 |
Why?
|
5' Untranslated Regions | 11 | 2020 | 255 | 1.320 |
Why?
|
Protein Biosynthesis | 13 | 2023 | 2093 | 1.190 |
Why?
|
alpha-Synuclein | 5 | 2020 | 773 | 1.150 |
Why?
|
Manganese | 2 | 2024 | 393 | 0.890 |
Why?
|
Iron | 11 | 2023 | 1811 | 0.810 |
Why?
|
Manganese Poisoning | 2 | 2019 | 13 | 0.810 |
Why?
|
Response Elements | 4 | 2019 | 308 | 0.760 |
Why?
|
Transcription Factor AP-1 | 2 | 2016 | 321 | 0.730 |
Why?
|
Lead Poisoning, Nervous System | 1 | 2019 | 12 | 0.650 |
Why?
|
Quinuclidines | 1 | 2019 | 27 | 0.640 |
Why?
|
Muscarinic Agonists | 1 | 2019 | 91 | 0.620 |
Why?
|
Neurodegenerative Diseases | 3 | 2020 | 1089 | 0.610 |
Why?
|
Neuroblastoma | 2 | 2024 | 1266 | 0.580 |
Why?
|
Neuroprotective Agents | 2 | 2024 | 956 | 0.580 |
Why?
|
Interleukin-1beta | 2 | 2016 | 1027 | 0.530 |
Why?
|
Alzheimer Disease | 12 | 2023 | 8717 | 0.520 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 742 | 0.480 |
Why?
|
Thiophenes | 1 | 2019 | 570 | 0.470 |
Why?
|
Enterocytes | 1 | 2016 | 220 | 0.460 |
Why?
|
Interleukin-1 | 7 | 2008 | 1252 | 0.400 |
Why?
|
Interleukin-6 | 2 | 2016 | 3227 | 0.400 |
Why?
|
Amyloid beta-Peptides | 5 | 2023 | 3886 | 0.400 |
Why?
|
Neurotoxicity Syndromes | 1 | 2016 | 302 | 0.400 |
Why?
|
Lead | 1 | 2016 | 882 | 0.350 |
Why?
|
Growth Hormone | 3 | 1999 | 572 | 0.350 |
Why?
|
Alcoholism | 1 | 2020 | 1980 | 0.330 |
Why?
|
Neurons | 7 | 2020 | 9517 | 0.320 |
Why?
|
Parkinson Disease | 2 | 2020 | 2886 | 0.290 |
Why?
|
I-kappa B Proteins | 1 | 2008 | 210 | 0.290 |
Why?
|
Homeostasis | 2 | 2016 | 3345 | 0.280 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2008 | 2883 | 0.250 |
Why?
|
Iron Regulatory Protein 1 | 2 | 2013 | 40 | 0.200 |
Why?
|
Transcription, Genetic | 4 | 2000 | 7611 | 0.170 |
Why?
|
Lewy Bodies | 1 | 2020 | 141 | 0.170 |
Why?
|
RNA, Messenger | 12 | 2019 | 12793 | 0.170 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2000 | 367 | 0.170 |
Why?
|
Oxidative Stress | 2 | 2018 | 3139 | 0.160 |
Why?
|
Apoferritins | 1 | 2018 | 17 | 0.160 |
Why?
|
Cell Survival | 4 | 2024 | 5750 | 0.160 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 1999 | 393 | 0.150 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1999 | 347 | 0.140 |
Why?
|
Deferoxamine | 2 | 2016 | 155 | 0.140 |
Why?
|
Lysosomes | 1 | 2023 | 937 | 0.140 |
Why?
|
Horses | 2 | 1997 | 294 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2000 | 882 | 0.140 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 11923 | 0.140 |
Why?
|
Iron Chelating Agents | 2 | 2016 | 141 | 0.140 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9612 | 0.130 |
Why?
|
Epitope Mapping | 1 | 1997 | 301 | 0.130 |
Why?
|
S-Adenosylmethionine | 1 | 2018 | 219 | 0.130 |
Why?
|
Protein Precursors | 2 | 1999 | 1134 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2016 | 71 | 0.130 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 440 | 0.130 |
Why?
|
Prolactin | 2 | 1997 | 627 | 0.130 |
Why?
|
Epitopes | 2 | 1999 | 2526 | 0.110 |
Why?
|
Phosphorylation | 3 | 2016 | 8310 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1492 | 0.110 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 789 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2007 | 3968 | 0.110 |
Why?
|
Transcription Factors | 5 | 2016 | 12158 | 0.110 |
Why?
|
Radioimmunoassay | 1 | 1994 | 861 | 0.110 |
Why?
|
Molecular Sequence Data | 8 | 2013 | 17608 | 0.110 |
Why?
|
Down Syndrome | 2 | 2019 | 916 | 0.100 |
Why?
|
Cell Line, Tumor | 6 | 2024 | 17097 | 0.100 |
Why?
|
Cell Line | 7 | 2018 | 15567 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 694 | 0.100 |
Why?
|
Animals | 17 | 2022 | 168965 | 0.100 |
Why?
|
Dicloxacillin | 1 | 2011 | 9 | 0.090 |
Why?
|
Strophanthidin | 1 | 2011 | 15 | 0.090 |
Why?
|
Cardenolides | 1 | 2011 | 17 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1296 | 0.090 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.090 |
Why?
|
Humans | 30 | 2024 | 767040 | 0.090 |
Why?
|
Receptors, Opioid, delta | 1 | 2010 | 48 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2007 | 5130 | 0.090 |
Why?
|
Base Sequence | 7 | 2013 | 12414 | 0.090 |
Why?
|
Rats | 5 | 2019 | 23713 | 0.090 |
Why?
|
Chelating Agents | 2 | 2008 | 384 | 0.080 |
Why?
|
DNA | 2 | 2000 | 7210 | 0.080 |
Why?
|
Intelligence | 2 | 2020 | 925 | 0.080 |
Why?
|
Receptors, Opioid, mu | 1 | 2010 | 167 | 0.080 |
Why?
|
Signal Transduction | 5 | 2018 | 23621 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2329 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 2010 | 899 | 0.080 |
Why?
|
Consensus Sequence | 2 | 2000 | 363 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 457 | 0.080 |
Why?
|
NF-kappa B | 2 | 2016 | 2493 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7236 | 0.080 |
Why?
|
Caco-2 Cells | 1 | 2008 | 364 | 0.070 |
Why?
|
Mice | 11 | 2022 | 81912 | 0.070 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 300 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2008 | 5796 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1905 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3792 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2457 | 0.070 |
Why?
|
Cross Reactions | 2 | 1999 | 828 | 0.060 |
Why?
|
Morphine | 1 | 2010 | 658 | 0.060 |
Why?
|
Transfection | 6 | 2006 | 5753 | 0.060 |
Why?
|
Repressor Proteins | 1 | 1996 | 2979 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2020 | 4546 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1997 | 4349 | 0.060 |
Why?
|
Verbal Learning | 1 | 2007 | 459 | 0.060 |
Why?
|
Problem Solving | 1 | 2007 | 442 | 0.060 |
Why?
|
ADAM Proteins | 1 | 2006 | 242 | 0.060 |
Why?
|
Brain | 4 | 2020 | 27163 | 0.060 |
Why?
|
Multiprotein Complexes | 1 | 2010 | 1110 | 0.060 |
Why?
|
Heat-Shock Proteins | 2 | 1999 | 792 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 1999 | 9245 | 0.060 |
Why?
|
Mutation | 1 | 2008 | 30211 | 0.050 |
Why?
|
Tumor Cells, Cultured | 5 | 2002 | 6106 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13411 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2003 | 187 | 0.050 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2022 | 616 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2419 | 0.050 |
Why?
|
Biotin | 1 | 2022 | 255 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2815 | 0.050 |
Why?
|
Peptide Fragments | 3 | 1999 | 5141 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 3726 | 0.040 |
Why?
|
Astrocytes | 2 | 2006 | 1352 | 0.040 |
Why?
|
Trans-Activators | 2 | 2000 | 2856 | 0.040 |
Why?
|
Memory Disorders | 1 | 2007 | 1193 | 0.040 |
Why?
|
Rabbits | 2 | 1999 | 4751 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2000 | 126 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5022 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2000 | 221 | 0.040 |
Why?
|
Monocytes | 2 | 1999 | 2598 | 0.040 |
Why?
|
Protein Modification, Translational | 1 | 2018 | 21 | 0.040 |
Why?
|
Insulinoma | 1 | 1999 | 121 | 0.040 |
Why?
|
Blotting, Northern | 2 | 1999 | 1550 | 0.040 |
Why?
|
Models, Biological | 2 | 2008 | 9464 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2022 | 665 | 0.040 |
Why?
|
tau Proteins | 1 | 2008 | 2106 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 769 | 0.040 |
Why?
|
Swine | 2 | 1999 | 5987 | 0.040 |
Why?
|
Protein Binding | 4 | 2013 | 9327 | 0.040 |
Why?
|
Placental Lactogen | 1 | 1997 | 17 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6873 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 1999 | 179 | 0.040 |
Why?
|
Luciferases | 3 | 2005 | 713 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1677 | 0.040 |
Why?
|
Glucagon | 1 | 1999 | 534 | 0.040 |
Why?
|
Immunoglobulin Isotypes | 1 | 1997 | 158 | 0.030 |
Why?
|
Hair | 1 | 2020 | 508 | 0.030 |
Why?
|
Antibody Specificity | 1 | 1999 | 1062 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2000 | 1626 | 0.030 |
Why?
|
Hybridomas | 1 | 1997 | 442 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2010 | 874 | 0.030 |
Why?
|
Genes, Reporter | 3 | 2005 | 1526 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2005 | 6507 | 0.030 |
Why?
|
Mammals | 1 | 2000 | 1135 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1076 | 0.030 |
Why?
|
3T3 Cells | 1 | 1996 | 1081 | 0.030 |
Why?
|
Sheep | 1 | 1997 | 1449 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 7121 | 0.030 |
Why?
|
Stomach, Avian | 1 | 1994 | 1 | 0.030 |
Why?
|
Secretory Rate | 1 | 1994 | 82 | 0.030 |
Why?
|
Columbidae | 1 | 1994 | 40 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1085 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2011 | 7469 | 0.030 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1994 | 139 | 0.030 |
Why?
|
Cytokines | 2 | 1999 | 7446 | 0.030 |
Why?
|
Pituitary Gland, Anterior | 1 | 1994 | 142 | 0.030 |
Why?
|
Physostigmine | 1 | 2013 | 50 | 0.030 |
Why?
|
Dwarfism, Pituitary | 1 | 1994 | 39 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1997 | 2176 | 0.030 |
Why?
|
Species Specificity | 1 | 1997 | 2412 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 2005 | 221 | 0.030 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 1994 | 126 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4572 | 0.030 |
Why?
|
Mutagenesis | 1 | 1996 | 1227 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2013 | 1057 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 1994 | 273 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1994 | 1309 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2000 | 3738 | 0.020 |
Why?
|
Binding Sites | 1 | 2000 | 6014 | 0.020 |
Why?
|
Cattle | 1 | 1997 | 3813 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2000 | 2428 | 0.020 |
Why?
|
Lactation | 1 | 1994 | 392 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2000 | 1474 | 0.020 |
Why?
|
Biological Assay | 1 | 1994 | 626 | 0.020 |
Why?
|
Protease Nexins | 1 | 2010 | 39 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 18401 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2144 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 1994 | 1751 | 0.020 |
Why?
|
Hot Temperature | 1 | 1997 | 1441 | 0.020 |
Why?
|
Reference Standards | 1 | 1994 | 1011 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 1999 | 2429 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2006 | 7868 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2270 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2013 | 18989 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 1997 | 2217 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10869 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 810 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6226 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4522 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2013 | 862 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2013 | 1080 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1376 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8108 | 0.020 |
Why?
|
Fasting | 1 | 1994 | 1607 | 0.020 |
Why?
|
Models, Molecular | 1 | 1997 | 5388 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 2 | 2005 | 1366 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2415 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22361 | 0.020 |
Why?
|
Child | 2 | 2020 | 80771 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39317 | 0.020 |
Why?
|
Poly C | 1 | 2005 | 6 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5794 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 7059 | 0.010 |
Why?
|
RNA, Double-Stranded | 1 | 2006 | 292 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3828 | 0.010 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 222 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2006 | 694 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10748 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4426 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2010 | 2345 | 0.010 |
Why?
|
Dimercaprol | 1 | 2003 | 7 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3804 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2005 | 409 | 0.010 |
Why?
|
Clioquinol | 1 | 2002 | 23 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 1211 | 0.010 |
Why?
|
Paroxetine | 1 | 2003 | 181 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1647 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1999 | 5446 | 0.010 |
Why?
|
Drug Interactions | 1 | 2006 | 1419 | 0.010 |
Why?
|
Azithromycin | 1 | 2003 | 201 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9551 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 2000 | 81 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1504 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3587 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2000 | 147 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2005 | 1101 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2268 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 89046 | 0.010 |
Why?
|
Magnesium | 1 | 2002 | 815 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1994 | 14672 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3760 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2003 | 1331 | 0.010 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 1999 | 374 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11063 | 0.010 |
Why?
|
DNA Primers | 1 | 2000 | 2827 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1994 | 20169 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1132 | 0.010 |
Why?
|
Drug Approval | 1 | 2002 | 820 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14476 | 0.010 |
Why?
|
Adult | 1 | 2007 | 223317 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2005 | 2330 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2000 | 2163 | 0.010 |
Why?
|
Up-Regulation | 1 | 1999 | 4143 | 0.010 |
Why?
|
Liver | 1 | 2005 | 7578 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5792 | 0.010 |
Why?
|
Insulin | 1 | 2000 | 6602 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40154 | 0.000 |
Why?
|
Female | 1 | 1994 | 396660 | 0.000 |
Why?
|
United States | 1 | 2002 | 72971 | 0.000 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_